Global Platelet-rich Plasma Market: Analyst’s Estimations

While the concept of minimally invasive surgery is currently being harnessed furiously, the technology is limited in terms of applications and is expensive. Meanwhile, rapid and efficient healing post a surgical procedure remains a therapeutic-stage of great importance for the caregivers and platelet-rich plasma (PRP) has been serving the cause adequately. As the world continues to witness growing prevalence orthopedic disorders that need surgery, and the trend of cosmetic surgeries engulfs developed regions with vast geriatric populations, the demand in the global PRP market is primed to attain new heights. According to the findings of this business and commerce report, the demand in the global platelet rich plasma market will expand at an impressive CAGR of 12.7% during the forecast period of 2017 to 2024. In terms of revenue, the global PRP market is estimated to be worth US$451.9 million, swelling up from its moderate valuation of US$195.2 million as of 2017.

global platelet rich plasma market

P-PRP Segment to Remain Dominant, but P-PRF Segment to Exhibit Higher CAGR

Leukocyte-platelet rich plasma (L-PRP), pure-platelet-rich fibrin (P-PRF), and pure-platelet rich plasma (P-PRP) constitute the key market segments based on product. Among these, the P-PRP segment provided for the most prominent chunk of demand and is expected to attain a valuation of US$291.2 million by 2023. Pure platelet-rich plasma, also called leukocyte-poor platelet-rich plasma, is blood plasma that contains only platelets and trace amount of leukocytes. P-PRP has richer content of platelets compared to the conventional variants of PRP, which is the key factor aiding its growth.

While P-PRP segment is expected to remain dominant over the next few years, it is the P-PRF segment, which is expected record a higher CAGR during the course of the forecast period. P-PRF exhibits higher efficiency and the presence of a large number of leukocytes and stem cells. This is anticipated to bolster demand from the segment significant in the near future.

North America to Remain Dominant Regional PRP Market through Forecast Period

Regionally, the global platelet rich plasma market can be segmented into Asia Pacific, Europe, Latin America, the Middle East and Africa, and North America. Among these regions, North America emerged dominant in 2017 with a share of over 48% in the global platelet rich plasma market. The increasing incidence of orthopedic diseases and sports injuries, coupled with the availability of improved diagnostics and advanced healthcare facilities augmented the demand for PRP from North America. Going forward, the high uptake of PRP products will seal North America’s dominance in the global market over the forecast period.

In 2017, Europe emerged as the second-leading market for platelet rich plasma and is also expected to retain its position during the forecast period. The rising demand for cosmetic procedures across the leading economies will aid the expansion of PRP market in Europe. Besides this, the market players will also have a highly lucrative market in Asia Pacific. The growth witnessed by the PRP market in Asia Pacific will be at a phenomenal pace due to the rising geriatric population and the increasing demand for latest cosmetic surgeries in the region.

At the forefront of the global platelet rich plasma market, companies such as Nuo Therapeutics, Regen Lab SA, DePuy Synthes Inc., ISTO Biologics, Regen Lab SA, Emcyte Corp., Arthrex Inc., AdiStem Ltd., Zimmer Biomet, Exactech Inc., Cesca Therapeutics Inc Stryker Corp., and Harvest Technologies Corp will register their prominence.

Global Platelet Rich Plasma (PRP) Market: Overview

Platelet rich plasma (PRP) is a blood plasma product in which concentration of platelets is elevated four to eight times than normal blood platelet concentration. PRP is also called platelet rich gel, platelet enriched plasma and platelet enriched gel. PRP is an effective treatment to treat various diseases such as orthopedic diseases, sports injuries, neurological diseases and cardiothoracic diseases. In addition, PRP therapy has an extensive application in cosmetic industry. This report studies the current scenario as well as future market potential for PRP globally.

The market overview section of the report comprises qualitative analysis of the overall PRP market considering the factors determining the market dynamics such as drivers, restraints and opportunities, along with Porter’s five force analysis and market attractiveness analysis. In addition, such as market opportunity analysis, and key industry developments has also been provided. Key industry developments include the major events occurred in past decade and are expected to occur during the forecast period and are likely to affect the market dynamics.

Global Platelet Rich Plasma (PRP) Market: Segmentation

The global PRP market has been segmented on the basis of types, origins and applications. On the basis of types, the global PRP market is categorized as pure-PRP (P-PRP), leukocyte-rich PRP (L-PRP) and pure-platelet-rich fibrin (P-PRF). Moreover, on the basis of origin, the PRP market has been segmented into autologous, homologous and allogeneic PRP.

Furthermore, on the basis of applications, the global PRP market has been classified as neurosurgery, cosmetic surgery, orthopedic surgery, general surgery and others (cardiothoracic surgery, urology, periodontal surgery and oral and maxillofacial surgery). The market for these types, origins and applications has been extensively analyzed on the basis of factors such as usage pattern, sales revenue, geographic presence and technological developments. The market size and forecast in terms of revenue (USD million) for each of these segments have been provided for the period 2014 to 2024, considering 2016 as the base year. The report also provides the compounded annual growth rate (CAGR) for each segment for the forecast period 2017 to 2024.

Geographically, the PRP market has been classified into four segments namely, North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. The market size and forecast for each region has been provided for the period 2014 to 2024, in terms of origin, types and applications, along with the CAGR (%) for the forecast period 2017 to 2024.

Global Platelet Rich Plasma (PRP) Market: Competitive Landscape

The report also provides a section on the competitive landscape, wherein the market share analysis of leading players in the global PRP market, in terms of percentage share in 2015 has been discussed. A list of recommendations has also been included for new entrants as well as existing market players to help them establish a strong presence in the market and increase their market share.

It concludes with the profiles of major players in the global PRP market such as AdiStem Ltd., Arthrex, Inc., Biomet, Inc., Cesca Therapeutics, Inc., DePuy Synthes, Inc., EmCyte Corporation, Exactech, Inc., Harvest Technologies Corp., Nuo Therapeutics, Inc., Regen Lab SA, and Stryker Corporation. The major market players are evaluated on various parameters such as company overview, financial overview, product portfolio, business strategies and recent developments.